A Pharmacovigilance Study on Comparative Safety Assessments of Delamanid, Ofloxacin, Levofloxacin and Bedaquiline, in Tertiary Healthcare of Multi-Drug Resistant Tuberculosis

Authors
Category Primary study
JournalInternational Journal of Toxicological and Pharmacological Research
Year 2022
This article has no abstract
Epistemonikos ID: 7e0c4823e3a4bdfbebee3e6cd2aee551694d7e6d
First added on: Feb 15, 2025